SIGLEC1 and breast carcinoma: For instance, in melanoma (71)and breast cancer (72), subcapsular sinus macrophages, particularly CD169+ subsets, act as tumor suppressors by inhibiting B cell activation, possibly through forming a physical barrier that restricts B cell activity (71, 73, 74).